If there was any question that machine learning would spawn chip designs aimed specifically at those applications, those doubts were laid to rest this year. The last 12 months have seen a veritable of explosion of silicon built for this new application space.
IBM is teaming up with four research institutions in an effort to study the effects of the human microbiome on autoimmune diseases. The effort, known as the Microbiome Immunity Project, is purported to be the “largest study to date of the bacteria in the human microbiome.”
At the Hot Chips conference this week, Microsoft has revealed its latest deep learning acceleration platform, known as Project Brainwave, which the company claims can deliver “real-time AI.” The new platform uses Intel's latest Stratix 10 FPGAs.
While AI is poised to sweep through major sectors of the economy over the next decade, perhaps no industry should be more welcoming to this technology than that of healthcare. And given that the US is the most technologically advanced nation in the world, and the one with the most expensive healthcare, the country could end up being the proving ground for AI-powered medicine.